Ethicon Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$52.9M
Doctors Paid
5,506
Transactions
25,125
2024 Total
$3.5M
Payment Breakdown by Category
Consulting$13.1M (24.7%)
Research$10.1M (19.1%)
Travel$1.6M (3.1%)
Food & Beverage$771,735 (1.5%)
Royalty/License$17,670 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.1M | 252 | 47.4% |
| Consulting Fee | $13.1M | 4,133 | 24.7% |
| Unspecified | $10.1M | 2,170 | 19.1% |
| Travel and Lodging | $1.6M | 5,702 | 3.1% |
| Acquisitions | $1.6M | 18 | 3.1% |
| Food and Beverage | $771,735 | 12,578 | 1.5% |
| Education | $390,700 | 174 | 0.7% |
| Space rental or facility fees (teaching hospital only) | $203,504 | 64 | 0.4% |
| Royalty or License | $17,670 | 2 | 0.0% |
| Gift | $1,014 | 32 | 0.0% |
Payments by Type
General
$42.8M
22,955 transactions
Research
$10.1M
2,170 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung | $1.8M | 0 | 185 |
| Research to further inform thinking about the role of LINX for Reflux Disease | $1.6M | 0 | 738 |
| LINX Reflux Management System Clinical Study in Patients with Hiatal Hernia >3 -TRX-2019-02 - Reginald Bell, M.D. | $848,591 | 0 | 91 |
| A Long Term Prospective Observational Post Market Clinical Follow-Up (PMCF) registry of Ethicon Gynecare Pelvic Mesh Products for The Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse | $619,692 | 0 | 75 |
| A Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue Lesions | $523,114 | 0 | 118 |
| The CALIBER Study Randomized Controlled Trial of LINX versus Double-dose Proton-pump Inhibitor Therapy for Reflux Disease | $469,975 | 1 | 46 |
| A Post-Approval Study for the LINX Reflux Management System | $366,335 | 0 | 63 |
| A prospective Multi Center multispecialty evaluation of STRATAFIX Spiral PDS Plus Knotless Tissue Control Device in robotic procedures | $300,002 | 0 | 107 |
| A long term prospective Post Market Clinical Follow-up (PMCF) of the GYNECARE TVT EXACT Continence System for the treatment of Stress Urinary Incontinence. | $216,441 | 0 | 59 |
| Early Post-Operative Outcomes Following mini-Percutaneous Nephrolithotomy with the MONARCH Platform, Urology | $203,497 | 0 | 16 |
| A Prospective, Multicenter Study of Reflux Management with the LINX System for Gastroesophageal Reflux Disease after Laparoscopic Sleeve Gastrectomy | $199,408 | 0 | 18 |
| A Multicentered Study to Evaluate NEUWAVE Microwave Ablation System Using Ablation Confirmation in Patients With A Soft Tissue Liver Lesion | $180,287 | 0 | 37 |
| A Post Approval Study of the LINX Reflux Management System | $175,062 | 0 | 116 |
| A Post-Approval Study of the LINX Reflux Management System | $165,498 | 0 | 61 |
| 18-BR-0001 | $156,937 | 0 | 31 |
| A Prospective, Multicenter Study of Reflux Management with the LINX System for Gastroesophageal REFlux Disease after Laparoscopic Sleeve Gastrectomy | $136,937 | 0 | 36 |
| North Carolina Blue Cross Blue Shield Esophageal Therapeutics (NC BEST) Registry /TRX-2021-05/ Dr. Darin Dufault | $123,245 | 0 | 16 |
| A prospective, multicenter, multispecialty evaluation of STRATAFIX Spiral PDS Plus Knotless Tissue Control Device in robotic procedures | $120,141 | 0 | 29 |
| Correlation of Targeted Ablation Defect and Minimal Margin with Local Tumor Progression after Treatment of Liver Malignancies NW201801 | $120,000 | 0 | 1 |
| Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung (TARGET) | $113,362 | 0 | 38 |
| A Prospective Multi Center Study of Reflux Management with the LINX System for Gastroesophageal REFlux Disease after Laparoscopic Sleeve Gastrectomy | $102,910 | 0 | 40 |
| A Prospective Study Evaluating the Safety and Effectiveness of EVARREST Fibrin Sealant Patch in Controlling Mild or Moderate Hepatic Parenchyma or Soft Tissue Bleeding During Open Abdominal, Retroperitonea l, Pelvic and Thoracic (non-cardiac) Surgery in Pediatric Patients | $95,103 | 0 | 23 |
| Knotless Suture in Revision Total Joint Arthroplasty: A Prospective Randomized Controlled Trial WC-2019-05 Dr. Schwarzkopf | $82,061 | 0 | 4 |
| Initial Experience of the Treatment of Renal Kidney Stones with the Monarch Platform-Urology | $74,303 | 0 | 7 |
| Needle based confocal laser endomicroscopy for the diagnosis of peripheral lung nodules by robotic navigational bronchoscopy. Fox Chase Dr. Manley | $63,334 | 0 | 1 |
| Investigation of a New Skin Closure Device, Dermabond PRINEO, for Total Shoulder Arthroplasty: A Randomized, Controlled Trial (US) | $60,300 | 0 | 5 |
| Ablation of Lung Lesions Using Microwave Energy A Basket Study ALLY NW201701 Dr. Hofstetter | $60,000 | 0 | 1 |
| Initial Experience of the Treatment of Renal Kidney Stones with the MonarchT Platform-Urology | $59,985 | 0 | 8 |
| A Prospective, Multicenter Study of Reflux Management with the LINX System for Gastroesophageal Reflux Disease after Laparoscopic Sleeve Gastrectomy | $57,460 | 0 | 11 |
| Stress Urinary Incontinence Surgery Registry Study AUGS 16-208 David Hale, MD | $50,000 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2020 |
|---|---|---|---|---|
| David Rubaltelli, M.d, M.D | Ophthalmology | Brooklyn, NY | $8.9M | $0 |
| Thomas Lendvay | Pediatric Urology | Seattle, WA | $6.3M | $0 |
| Hariharan Sundram, M.d, M.D | Pain Medicine | Newton, MA | $1.7M | $0 |
| Mihir Desai, M.d, M.D | Urology | Los Angeles, CA | $1.4M | $0 |
| Keith Kim, M.d, M.D | Surgery | Celebration, FL | $987,157 | $0 |
| Jason Rogers, M.d, M.D | Cardiovascular Disease | Sacramento, CA | $716,056 | $0 |
| Unknown Provider | — | — | $619,839 | $0 |
| Dr. Barry Gardiner, M.d, M.D | Surgery | San Ramon, CA | $584,486 | $0 |
| Jaime Landman, M.d, M.D | Urology | Orange, CA | $581,629 | $0 |
| Douglas Hogarth | Pulmonary Disease | Chicago, IL | $558,954 | $0 |
| Dr. Howard Fine, Md Mhsc, MD MHSC | Ophthalmology | New Brunswick, NJ | $544,255 | $0 |
| Glenn Preminger, M.d, M.D | Urology | Durham, NC | $539,450 | $0 |
| Dr. Santiago Horgan | Surgery | San Diego, CA | $510,779 | $0 |
| Dr. Kamran Haghighat, Md, MD | Internal Medicine | Anaheim, CA | $350,000 | $0 |
| Dr. Ryan Nunley, Md, MD | Adult Reconstructive Orthopaedic Surgery | Saint Louis, MO | $331,766 | $0 |
| C Daniel Smith, Md, MD | Surgery | Atlanta, GA | $314,642 | $0 |
| Cristopher Garlitz, M.d, M.D | Urology | Seattle, WA | $302,069 | $0 |
| David Yang, M.d, M.D | Urology | Mankato, MN | $291,915 | $0 |
| John Lipham, Md, MD | Surgery | Los Angeles, CA | $285,547 | $0 |
| Thomas Smith, M.d, M.D | Internal Medicine | Sacramento, CA | $277,300 | $0 |
| Dr. Vivek Reddy, M.d, M.D | Clinical Cardiac Electrophysiology | New York, NY | $276,022 | $0 |
| Dr. Thomas Chi, Md, MD | Urology | Birmingham, AL | $274,839 | $0 |
| Dr. Saibal Kar, M.d, M.D | Cardiovascular Disease | Thousand Oaks, CA | $264,916 | $0 |
| Dr. Marshall Stoller, M.d, M.D | Urology | San Francisco, CA | $264,183 | $0 |
| Dr. Mitchell Humphreys, M.d, M.D | Urology | Phoenix, AZ | $255,685 | $0 |
Ad
Top Products
- Monarch Platform $6.1M
- LINX Reflux Management System $3.7M
Associated Products (15)
- Monarch Platform $7.3M
- LINX Reflux Management System $7.1M
- DERMABOND Portfolio $1.2M
- GYNECARE INTERCEED $631,584
- MONARCH $505,711
- GYNECARE TVT EXACT $294,069
- PROLENE $239,147
- VICRYL Mesh $60,878
- PROLENE Polypropylene Suture $48,389
- EVOTECH $29,236
- OTHER / NA $21,312
- LAPRA-TY Suture Clip $20,284
- Endopath Xcel $19,952
- ETHICON PHYSIOMESH $13,600
- PDS II (polydioxanone) Suture $12,265
Payment Categories
- Food & Beverage $771,735
- Consulting $13.1M
- Travel & Lodging $1.6M
- Research $10.1M
- Royalties $17,670
About Ethicon Inc.
Ethicon Inc. has made $52.9M in payments to 5,506 healthcare providers, recorded across 25,125 transactions in the CMS Open Payments database. In 2024, the company paid $3.5M. The top product by payment volume is Monarch Platform ($6.1M).
Payments were distributed across 130 medical specialties. The top specialty by payment amount is Ophthalmology ($9.5M to 8 doctors).
Payment categories include: Food & Beverage ($771,735), Consulting ($13.1M), Research ($10.1M), Travel & Lodging ($1.6M), Royalties ($17,670).
Ethicon Inc. is associated with 15 products in the CMS Open Payments database, including Monarch Platform, LINX Reflux Management System, and DERMABOND Portfolio.